ABT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Abbott Laboratories

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.
CEO
Robert Ford
Employees
109000
Headquarters

100 Abbott Park Rd
Abbott Park, Illinois 60064-3500
Phone: 12246676100
www.abbott.com

News

Abbott Laboratories (NYSE: ABT) Is Down -20.40% So Far This Year. Analysts Expect A Significant Price Rally
Aug 17, 2022 20:00pm

Abbott Laboratories (NYSE:ABT) price is hovering lower on Tuesday, August 16, dropping -1.17% below its previous close. A look at today’s price movement shows that the recent level at last check reads $112.03, with intraday deals fluctuating between $111.43 and $112.53. The company’s 5Y monthly beta was ticking 0.74 while its P/E ratio in the … Abbott Laboratories (NYSE: ABT) Is Down -20.40% So Far This Year. Analysts Expect A Significant Price Rally Read More »


Source:Stocks Register
The Irish Times view on the new investment from Abbott Laboratories: part of an encouraging trend
Aug 14, 2022 19:50pm

Recent months have brought a strong inflow of FDI announcements, but there is work to be done to maintain the trend


Source:The Irish Times
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,500 Today
Aug 12, 2022 14:30pm

Abbott Laboratories (NYSE: ABT ) has outperformed the market over the past 10 years by 1.78% on an annualized basis producing an average annual return of 13.29%. Currently, Abbott Laboratories has a market capitalization of $193.88 billion. Buying $1000 In ABT: If an … Full story available on Benzinga.com


Source:Benzinga
Abbott Labs'' Dividend Strength Is Top Notch (NYSE:ABT)
Aug 10, 2022 12:49pm

Dividend Aristocrat Abbott Laboratories is one of our favorite healthcare names.


Source:Seeking Alpha
Panel launches new MDLs for Abbott baby formula, Merck''s Gardasil
Aug 05, 2022 19:34pm

A federal judicial panel has created new federal mass tort dockets to handle claims that babies sickened by formula from an Abbott Laboratories plant closed earlier this year over safety concerns, and that Merck & Co Inc''s Gardasil vaccine against human papillomavirus caused serious autoimmune conditions.


Source:Reuters
Abbott Laboratories: A Lesser Johnson & Johnson? (NYSE:ABT)
Aug 04, 2022 22:12pm

Similar to JNJ, ABT is a broadly diversified medical device and healthcare company. It has received much attention for its strong performance during the pandemic.


Source:Seeking Alpha
Blood Screening Market Estimated to Experience a Hike in Growth by 2021-2031 | Grifols , F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc., bioMérieux
Aug 03, 2022 06:32am

The blood screening market size was USD 2.8 billion in 2021 and it is anticipated to reach USD 5.5 billion in 2031, growing at a CAGR of 6.9% from 2022-2031. Global Blood Screening Market report from Global Insight Services is the


Source:OpenPR
If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today
Jul 31, 2022 11:55am

The real question may be, has Abbott been a better buy than AbbVie since the spinoff?


Source:The Motley Fool
Abbott Laboratories campus in Minnetonka sells for $53 million
Jul 28, 2022 21:37pm

Austin, Texas-based Virtus Real Estate Capital acquired the Abbott Laboratories Life Science Campus in Minnetonka for more than $53 million last week.


Source:Business Journals
Is Abbott Laboratories a Buy?
Jul 28, 2022 15:45pm

This stock rewards investors who have patience.


Source:The Motley Fool
Abbott Labs PT Lowered to $135 at Argus
Jul 28, 2022 12:02pm

https://www.investing.com/news/pro/abbott-labs-pt-lowered-to-135-at-argus-432SI-2856757


Source:Investing.com
Here''s How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Jul 27, 2022 16:27pm

Abbott Laboratories (NYSE: ABT ) has outperformed the market over the past 10 years by 2.01% on an annualized basis producing an average annual return of 13.13%. Currently, Abbott Laboratories has a market capitalization of $190.75 billion. Buying $1000 In ABT: If … Full story available on Benzinga.com


Source:Benzinga
7 Large-Cap Stocks to Buy on the Dip
Jul 27, 2022 11:10am

Following this year’s sell-off, seasoned investors are increasingly hunting for large-cap stocks to buy on the dip. For instance, the S&P 500 index and Dow Jones Industrial Average have lost 185 and 13% so far in 2022. As investors rotate toward safer bets, undervalued large-cap stocks could offer attractive upside potential for long-term investors. Recent numbers from the Bureau of Labor Statistics reported show the consumer price index increased 9.1% from June 2021. Put another way, the U.S. is facing its highest inflationary pressure in four decades. Wall Street now expects the Federal Reserve to continue its aggressive position on taming inflation. Many analysts are already bracing for a full percentage point hike in interest rates in late July. Amidst such macroeconomic headwinds, it could be prudent to get more defensive by investing in large-cap stocks. Such shares boast mature businesses with wide moats. Investors can typically rely on them for stable revenue, earnings growth and dividends.


Source:InvestorPlace
Abbott Labs PT Lowered to $104 at Goldman Sachs
Jul 25, 2022 14:52pm

https://www.investing.com/news/pro/abbott-labs-pt-lowered-to-104-at-goldman-sachs-432SI-2853223


Source:Investing.com
WHO declares monkeypox outbreak a global health emergency (NYSE:ABT)
Jul 23, 2022 14:37pm

The World Health Organization ((WHO)) designated the current monkeypox outbreak a public health emergency of international concern ((PHEIC)) on Saturday


Source:Seeking Alpha
Medical Wearables Development Reaches Fever Pitch
Jul 21, 2022 13:00pm

FinancialBuzz.com News Commentary NEW YORK , July 21, 2022 /PRNewswire/ -- The wearable technology sector continues to prove its potential across various industries. Advancements in sensor technology are making such products more appealing in industrial application, in healthcare and consumer electronics. Generally, wearable devices are a category of electronic devices that can be worn as accessories, embedded in clothing, implanted on the user''s body, or even tattooed on the skin. The devices are hands-free gadgets with practical uses, powered by microprocessors and enhanced with the ability to send and receive data via the Internet. Furthermore, the rising popularity of connected devices and the Internet of Things (IoT), as well as the rapid growth of a technologically literate population globally, are anticipated to fuel the demand for wearable technology. Overall, according to data provided by Grand View Research, the global wearable technology market size was valued at USD 40.65 Billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13.8% from 2021 to 2028.


Source:Benzinga
Abbott Labs PT Lowered to $125 at BofA Securities
Jul 21, 2022 09:40am

https://www.investing.com/news/pro/abbott-labs-pt-lowered-to-125-at-bofa-securities-432SI-2850424


Source:Investing.com
Abbott Laboratories Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6%
Jul 21, 2022 06:52am

WESTON (dpa-AFX) - The following are some of the biotech companies that reported earnings and provided an update on their pipeline yesterday.1. Abbott Laboratories (ABT), which reported encouragin…


Source:Finanz Nachrichten
Abbott Labs PT Lowered to $123 at Citi
Jul 20, 2022 21:12pm

https://www.investing.com/news/pro/abbott-labs-pt-lowered-to-123-at-citi-432SI-2850069


Source:Investing.com
From at-home tests for COVID-19 to lotions and fragrances, inflation is reshaping what we buy
Jul 20, 2022 19:20pm

Earnings from Abbott Labs and a revenue warning form Bath & Body Works show inflation is determining what we have to buy vs. what we want to buy.


Source:Business Insider
Gold Prices Settle Lower; Vascular Biogenics Shares Plummet
Jul 20, 2022 18:36pm

U.S. stocks traded mostly higher toward the end of trading, with the S&P index gaining around 0.5% on Wednesday. The Dow traded up 0.01% to 31,830.59 while the NASDAQ rose 1.42% to 11,879.02. The S&P also rose, gaining, 0.52% to 3,957.13. Also check this: Mastercard to $425? Plus Raymond James Predicts $2,350 For This Stock Leading and Lagging Sectors Information technology shares rose 1.1% on Wednesday. Meanwhile, top gainers in the sector included Pagaya Technologies Ltd. (NASDAQ: PGY ), up 96% and Stronghold Digital Mining, Inc. (NASDAQ: SDIG ) up 44%. In trading on Wednesday, utilities shares fell 1.4%. Top Headline Abbott Laboratories (NYSE: ABT ) reported better-than-expected earnings for its second quarter and raised its forecast. The company reported Q2 FY22 adjusted EPS of $1.43, up 22.2% Y/Y, better than the consensus of $1.12. Q2 sales of $11.3 billion increased 10.1% on a reported basis and 14.3% on an organic basis, beating the consensus of $10.29 billion. Abbott has increased FY22 adjusted EPS guidance to $4.90 from the earlier guidance of $4.70, compared to the consensus of $4.88.


Source:Benzinga
Abbott Labs PT Lowered to $112 at Evercore ISI
Jul 20, 2022 17:08pm

https://www.investing.com/news/pro/abbott-labs-pt-lowered-to-112-at-evercore-isi-432SI-2849888


Source:Investing.com
Abbott Laboratories (ABT) Q2 2022 Earnings Call Transcript
Jul 20, 2022 16:30pm

ABT earnings call for the period ending June 30, 2022.


Source:The Motley Fool
New filing by ABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
Jul 20, 2022 16:22pm

The ABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE successfully filed their F3XN JULY MONTHLY with the coverage period of 06/01/2022 to 06/30/2022 and a confirmation ID of FEC-1617672 *********CommitteeId: C00040279 | FilingId: 1617672 | FormType: F3XN | CoverageFrom: 06/01/2022 | CoverageThrough: 06/30/2022 | ReportType: JULY MONTHLY*********


Source:The FEC
Tech Shares Move Higher, Nasdaq Jumps 200 Points
Jul 20, 2022 16:01pm

U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining more than 200 points on Wednesday. The Dow traded up 0.29% to 31,920.00 while the NASDAQ rose 1.76% to 11,919.51. The S&P also rose, gaining, 0.82% to 3,969.13. Also check this: Global Cryptocurrency Market Cap Surpasses This Major Level, Here Are The Top Crypto Movers For Tuesday Leading and Lagging Sectors Consumer discretionary shares rose 1.5% on Wednesday. Meanwhile, top gainers in the sector included Workhorse Group Inc. (NASDAQ: WKHS ), up 16% and AMCON Distributing Company (NYSE: DIT ) up 14%. In trading on Wednesday, health care shares fell 0.5%. Top Headline Abbott Laboratories (NYSE: ABT ) reported better-than-expected earnings for its second quarter and raised its forecast. The company reported Q2 FY22 adjusted EPS of $1.43, up 22.2% Y/Y, better than the consensus of $1.12. Q2 sales of $11.3 billion increased 10.1% on a reported basis and 14.3% on an organic basis, beating the consensus of $10.29 billion.


Source:Benzinga
Recap: Abbott Laboratories Q2 Earnings
Jul 20, 2022 11:58am

Abbott Laboratories (NYSE: ABT ) reported its Q2 earnings results on Wednesday, July 20, 2022 at 07:30 AM. Here''s what investors need to know about the announcement. Earnings Abbott Laboratories beat estimated earnings by 27.68%, reporting an EPS of $1.43 versus … Full story available on Benzinga.com


Source:Benzinga
Abbott Laboratories Q2 Profit Increases, beats estimates
Jul 20, 2022 11:58am

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) revealed earnings for its second quarter that increased from the same period last year and beat the Street estimates.The company''s earnings came…


Source:Finanz Nachrichten
Abbott Laboratories Posts Better-Than-Expected Q2 Sales, Earnings
Jul 20, 2022 11:53am

Abbott Laboratories on Wednesday topped estimates for second-quarter sales and earnings and guided higher for the full year.


Source:Investor''s Business Daily
Abbott Labs sales hit $11.3B in Q2
Jul 20, 2022 11:41am

Abbott Laboratories revealed on Wednesday that its net sales in the second quarter reached $11.3 billion. The company''s earnings per share surpassed analyst expectations to land at $1.43 Further…


Source:Breaking the News 24/7
Abbott Labs sales at $11.3B in Q2
Jul 20, 2022 11:41am

Abbott Laboratories revealed on Wednesday that its net sales in the second quarter reached $11.3 billion. More to come…...


Source:Breaking the News 24/7
All eyes on Abbott Q2 results amid potential impact due to baby formula woes (NYSE:ABT)
Jul 19, 2022 15:59pm

Abbott Laboratories (ABT) is scheduled to announce Q2 earnings results on Wednesday, July 20th, before market open.The consensus EPS Estimate is $1.14 (-2.6% Y/Y) and the consensus…


Source:Seeking Alpha
See Which Of The Latest 13F Filers Holds Abbott Laboratories
Jul 19, 2022 14:17pm

At Holdings Channel, we have reviewed the latest batch of the 42 most recent 13F filings for the 06/30/2022 reporting period, and noticed that Abbott Laboratories (Symbol: ABT) was held by 25 of these funds. When hedge fund managers appear to be thinking alike, we find it is a g


Source:Nasdaq
Preview: Abbott Laboratories''s Earnings
Jul 19, 2022 14:07pm

Abbott Laboratories (NYSE: ABT ) is set to give its latest quarterly earnings report on Wednesday, 2022-07-20. Here''s what investors need to know before the announcement. Analysts estimate that Abbott Laboratories will report an earnings per share (EPS) of $1.12. Abbott Laboratories bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com


Source:Benzinga
Is Abbott Laboratories Stock A Sell Before Upcoming Earnings? (NYSE:ABT)
Jul 18, 2022 19:05pm

Abbott''s above-expectations Q1 2022 results were mainly boosted by robust COVID-19 testing sales. Read more to find out if ABT stock is a sell before earnings.


Source:Seeking Alpha
Clinical Chemistry Analyzers Market size to surpass around US$ XX Bn by 2031 | F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Abbott Laboratories (US)
Jul 18, 2022 07:57am

New York, 2022-Jul-14 — /EPR Network/ — Global Clinical Chemistry Analyzers Market report from Global Insight Services is the single authoritative source of intelligence on [read full press release…]


Source:Express Press Release Distribution
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the Firm
Jul 16, 2022 01:00am

NEW YORK--(BUSINESS WIRE)-- #ABT--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) on behalf of Abbott stockholders. Our investigation concerns whether Abbott has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. The investigation focuses on whether the Company issued false and/or misl


Source:Business Wire
Canned And Ambient Food Global Market Report 2022
Jul 15, 2022 15:26pm

Major companies in the canned and ambient food market include Nestle S. A. , Abbott Laboratories, The Campbell Soup Company, Unilever plc, The Kraft Heinz Company, Del Monte Pacific Limited, Bonduelle Group, Seneca Foods Corporation, La Doria S. Major companies in the canned and ambient food market include Nestle S. A. , Abbott Laboratories, The Campbell Soup Company, Unilever plc, The Kraft Heinz Company, Del Monte Pacific Limited, Bonduelle Group, Seneca Foods Corporation, La Doria S.


Source:GlobeNewswire
Electrolyte Mixes Global Market Report 2022
Jul 15, 2022 15:11pm

Major players in the electrolyte mixes market are PepsiCo Inc. , The Coca-Cola Company, LyteLine LLC, Nestle Health Science S. A. , Vega, Ultima Health Products Inc. , Abbott Laboratories, Tailwind Nutrition, Cargill, Prestige Brands Holdings Inc. Major players in the electrolyte mixes market are PepsiCo Inc. , The Coca-Cola Company, LyteLine LLC, Nestle Health Science S. A. , Vega, Ultima Health Products Inc. , Abbott Laboratories, Tailwind Nutrition, Cargill, Prestige Brands Holdings Inc.


Source:GlobeNewswire
Is Abbott Labs (ABT) Still a Safe Investment Pick?
Jul 15, 2022 12:09pm

Diamond Hill Capital, an investment management firm, published its “Diamond Hill Large Cap Concentrated Fund” first-quarter 2022 investor letter – a copy of which can be downloaded here.


Source:Insider Monkey
Nutritional Supplements Market Pegged for Robust Expansion by 2031 | Type, Application, Scope & Key Companies | Abbott Laboratories, Bayer, Herbalife International, Koninklijke DSM
Jul 15, 2022 11:04am

New York, 2022-Jul-14 — /EPR Network/ — Global Nutritional Supplements Market report from Global Insight Services is the single authoritative source of intelligence on Nutritional [read full press release…]


Source:Express Press Release Distribution
Sleeping Pills Market to See Major Growth by 2028 : Merck, Pfizer, GlaxoSmithKline
Jul 13, 2022 19:29pm

Sleeping Pills Market 2022-2028 New Jersey, NJ -- ( SBWIRE ) -- 07/13/2022 -- 2022-2030 Report on Global Sleeping Pills Market by Player, Region, Type, Application and Sales Channel is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Sleeping Pills Market. Some of the key players profiled in the study are Abbott Laboratories, Actellon Pharmaceuticals, Allegiant Health, Ambitropin, Apotex, Aurobindo Pharma, Becton Dickinson, Cayman Chemical, GlaxoSmithKline, Hayao, Merck, Pfizer, Sanofi, Takeda Pharmaceutical & Teva Pharmaceuticals. Get free access to sample report @ https://www.htfmarketreport.com/sample-report/4097378-2022-2030-report-on-global-sleeping-pills-market Sleeping Pills Market Overview: The study provides comprehensive outlook vital to keep market knowledge up to date segmented by Hospital Pharmacy & Retail Pharmacy, , Zolpidem, Eszopiclone (Lunesta), Ramelteon (Rozerem), Ativan (Lorazepam) & Adapin (Doxepin) and 18+ countries across the globe along with insights on emerging & major players.


Source:SBWire
Analyzing Abbott Laboratories''s Short Interest
Jul 13, 2022 13:23pm

Abbott Laboratories''s (NYSE: ABT ) short percent of float has fallen 7.41% since its last report. The company recently reported that it has 12.98 million shares sold short , which is 0.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.4 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com


Source:Benzinga
5 Dividend Kings That Income Investors Can Count On
Jul 13, 2022 12:29pm

The Dividend Kings list is a great way to find companies with a long-term commitment to paying shareholders. The Dividend Kings have not only consistently paid increasing dividends for decades but have also outperformed the market with their returns in the past decade. A company’s dividend history is important for investors when deciding which stocks to buy. Dividend stocks are more stable because these companies generate stable income for the passive investor. They also tend to be less volatile than stocks that don’t pay dividends. 5 Best Stocks to Buy if You Have $100 to Spend This list of Dividend Kings is perfect for you if you’re trying to devise a portfolio that can withstand any market conditions. These stocks have been paying dividends for decades without missing any payments or reducing the rate. This ensures that your money stays secure. Below are five dividend kings considered a safe buy: LOW Lowe’s Companies $182.24 ABT Abbott Laboratories $108.74 FRT Federal Realty Investment Trust $98.98 PEP PepsiCo $170.51 KMB Kimberly-Clark $136.19 Dividend Kings: Lowe’s Companies (LOW) Source: Helen89 / Shutterstock.com Dividend Yield: 2.33% Lowe’s Companies (NYSE: LOW ) is a Fortune 100 company that provides retail home improvement and appliance services.


Source:InvestorPlace
Abbott''s Deep Brain Stimulation Receives FDA''s Breakthrough Device Tag To Manage Depression
Jul 12, 2022 14:20pm

The FDA has granted Breakthrough Device Designation to Abbott Laboratories (NYSE: ABT ) deep brain stimulation (DBS) system in treatment-resistant depression (TRD), a form of major depressive disorder (MDD). Abbott''s DBS system is a personalized, adjustable therapy that involves implanting thin wires (or leads) – into targeted areas of the … Full story available on Benzinga.com


Source:Benzinga
Molecular Quality Control Market See Incredible Growth 2022-2028 | Abbott Laboratories, Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific
Jul 12, 2022 14:06pm

Overview The documentation of the market research report contains various market analysis strategies that are involved to study the Global Molecular Quality Control Market such as PESTLE analysis, SWOT analysis and Five point analysis. All these strategies will help the readers


Source:OpenPR
$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Jul 11, 2022 16:09pm

Abbott Laboratories (NYSE: ABT ) has outperformed the market over the past 10 years by 2.16% on an annualized basis producing an average annual return of 13.1%. Currently, Abbott Laboratories has a market capitalization of $190.64 billion. Buying $1000 In ABT: If … Full story available on Benzinga.com


Source:Benzinga
Abbott’s Sturgis Facility Restarts Operations
Jul 11, 2022 13:58pm

Abbott Laboratories (ABT) has restarted the production of baby formula at its Sturgis, Michigan plant. The facility had been shuttered due to heavy rains and flooding in June. The plant, which resumed operations on July 1, has restarted the production of EleCare, which is a specialty baby formula. The plant reopened after a shutdown that lasted for months due to investigations into infections in babies who had consumed the products. Abbott is a key player in the infant formula space in the U.S., and the shutdown of its facility led to a major nationwide shortage of baby formula. The U.S.


Source:TipRanks
Abbott baby formula plant resumes operations after flooding (NYSE:ABT)
Jul 10, 2022 01:11am

Abbott Laboratories (ABT) has reopened its baby formula plant in Sturgis, Michigan, after flooding in the area forced the company to shut its operations last month, a company…


Source:Seeking Alpha
Functional Foods Global Market Report 2022
Jul 08, 2022 11:26am

Major players in the market are, Unilever, BNL Food Group, Dean Foods, The Coca-Cola Company, Arla Foods, Abbott Laboratories, PepsiCo Inc. , Kraft Foods Inc. , and Nestle. The global functional foods market is expected to grow from $180. Major players in the market are, Unilever, BNL Food Group, Dean Foods, The Coca-Cola Company, Arla Foods, Abbott Laboratories, PepsiCo Inc. , Kraft Foods Inc. , and Nestle. The global functional foods market is expected to grow from $180.


Source:GlobeNewswire
Will This Dry Eye Rapid Test Prove To Be A Rapid Success?
Jul 07, 2022 12:42pm

During the last few years of the COVID-19 pandemic, the term “rapid test” conjures images of overlong cotton swabs reaching heretofore untouched corners of nasal cavities. In reality, rapid tests aid doctors and medical professionals of all stripes in making proper and on-the-spot diagnoses of myriad conditions. Companies like Siemens Healthineers ADR (OTCMKTS: SMMNY) and Abbott Laboratories (NYSE: ABT ) have provided billions of rapid tests to help the world curb the spread of COVID-19, generating billions of dollars in revenue for the companies in the process. Regardless of the ailment, … Full story available on Benzinga.com


Source:Benzinga
Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King
Jul 07, 2022 10:39am

Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2022 contest. Bob Ciura’s pick for the contest is AbbVie (NYSE: ABBV ) stock. The stock market recently entered bear market territory. Although the S&P 500 index has regained some ground lately, there is a possibility of further declines. Inflation continues to roar, and in response the Federal Reserve is aggressively raising interest rates. In addition, the ongoing war between Russia and Ukraine has caused oil prices to spike. Putting it all together, and the U.S. economy could be on the verge of recession. When stock prices decline, investors can buffer their portfolios by holding high-quality dividend stocks. This is why I continue to recommend investors consider pharmaceutical giant AbbVie (NYSE: ABBV ). AbbVie continues to generate strong growth even in a difficult economic backdrop due to its high-quality product portfolio. AbbVie stock also has a high dividend yield, with regular dividend increases — AbbVie is one of just 65 Dividend Aristocrats , and one of just 44 Dividend Kings .


Source:InvestorPlace
FDA to help foreign baby formula makers to access U.S. market for long-term (NYSE:ABT)
Jul 06, 2022 19:42pm

The U.S. Food and Drug Administration ((FDA)) is set to announce measures to support foreign makers of baby formula to stay in the U.S


Source:Seeking Alpha
ABBOTT LABORATORIES INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories'' Directors and Officers for Breach of Fiduciary Duties – ABT
Jul 05, 2022 22:53pm

NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, reminds investors it is investigating whether certain directors and officers of Abbott Laboratories ("Abbott") (NYSE: ABT ) breached their fiduciary duties to Abbott and its shareholders. If you are an Abbott shareholder, you are encouraged to contact attorney Joe Pettigrew with Scott+Scott for additional information at (844) 818-6982 or jpettigrew@scott-scott.com . Scott+Scott is investigating whether members of … Full story available on Benzinga.com


Source:Benzinga
ABBOTT LABORATORIES INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
Jul 05, 2022 22:53pm

NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, reminds investors it is investigating whether certain directors and officers of Abbott Laboratories (“Abbott”) (NYSE: ABT) breached their fiduciary duties to Abbott and its shareholders. If you are an Abbott shareholder, you are encouraged to contact attorney Joe Pettigrew with Scott+Scott for additional information at (844) 818-6982 or jpettigrew@scott-scott.com .


Source:GlobeNewswire
Is CBD the Same Thing as Cannabis?
Jul 05, 2022 00:00am

Confused about the difference between CBD and cannabis? You’re not alone. But with some convenience stores now selling CBD — and the global CBD market projected to grow to $55 billion by 2028, according to Fortune Business Insights — the difference is something operators need to know. CBD, or cannabidiol, is one of the main…


Source:WTWH
Abbott: Successfully Handled The Infant Formula Crisis (NYSE:ABT)
Jul 04, 2022 15:06pm

Abbott (ABT) was caught in a middle of the infant formula crisis. Read this article to know why I think ABT stock may bounce back over the next year.


Source:Seeking Alpha
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
Jul 01, 2022 13:21pm

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm


Source:Business Wire
Teva appoints former Vertex exec as new head of R&D, CMO
Jul 01, 2022 00:00am

Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. With nearly 20 years of experience in all phases of […]


Source:WTWH
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
Jun 30, 2022 19:45pm

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm


Source:Business Wire
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why | AlphaStreet
Jun 30, 2022 17:13pm

Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment registering strong sales growth aided by the high demand for COVID-19 test kits. Typically, the company’s diversified business model comes in handy whenever it is challenged by unexpected events. Despite the high volatility […]


Source:AlphaStreet
Abbott Finds Support Around $100 (NYSE:ABT)
Jun 30, 2022 06:10am

Abbott has declined for roughly six consecutive months, falling about 40% from its late 2021 peak.


Source:Seeking Alpha
BD launches combination COVID-19, flu, RSV diagnostic test
Jun 30, 2022 00:00am

BD (NYSE:BDX) today announced it has launched a new molecular diagnostic combination test for SARS-CoV-2, influenza A and B and respiratory syncytial virus (RSV) following CE mark approval. The BD Max test uses a single nasal swab or nasopharyngeal swab sample to determine if a patient has COVID-19, the flu or RSV. Franklin Lakes, N.J.-based […]


Source:WTWH
Dexcom focuses on early diabetes diagnosis as COVID links emerge
Jun 29, 2022 00:00am

New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s…


Source:WTWH
Philips updates on testing results for recalled ventilators
Jun 28, 2022 00:00am

Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after […]


Source:WTWH
BLE MCUs target economical applications
Jun 27, 2022 00:00am

Texas Instruments expanded its connectivity portfolio with a new family of wireless microcontrollers (MCU) that enable high-quality Bluetooth Low Energy (LE) at half the price of competing devices. Featuring best-in-class standby current and radio-frequency (RF) performance, the SimpleLink Bluetooth LE CC2340 family is built on the foundation of TI’s decades of wireless connectivity expertise. Pricing […]


Source:WTWH
PHY conformance test tool to support UWB development efforts
Jun 27, 2022 00:00am

A FiRa-validated ultra-wideband (UWB) PHY Conformance Test Tool (PCTT) supports the further development of an open and standardized UWB ecosystem. With expertise and experience in wireless technology verification and certification, Rohde & Schwarz is well positioned to provide a test tool to support interoperability on the UWB physical layer as specified by FiRa. Thanks to […]


Source:WTWH
BLE MCUs target economical applications
Jun 27, 2022 00:00am

Texas Instruments expanded its connectivity portfolio with a new family of wireless microcontrollers (MCU) that enable high-quality Bluetooth Low Energy (LE) at half the price of competing devices. Featuring best-in-class standby current and radio-frequency (RF) performance, the SimpleLink Bluetooth LE CC2340 family is built on the foundation of TI’s decades of wireless connectivity expertise. Pricing […]


Source:WTWH
Here''s How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Jun 24, 2022 15:25pm

Abbott Laboratories (NYSE: ABT ) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market capitalization of $187.96 billion. Buying $1000 In ABT: If … Full story available on Benzinga.com


Source:Benzinga
''Absurd'' loophole can''t keep Abbott formula lawsuits in federal court -judge
Jun 23, 2022 21:01pm

Abbott Laboratories Inc cannot use a controversial legal loophole known as "snap removal" to keep lawsuits claiming that its Similac baby formula caused a deadly illness in premature infants in federal, rather than state, court, a federal judge has ruled.


Source:Reuters
Is There Any End in Sight to the Abbott Baby Formula Controversy?
Jun 23, 2022 12:24pm

The baby formula controversy at Abbott Laboratories (ABT) got exacerbated yet again after the Food and Drug Administration (FDA) revealed that it had initiated an investigation linked to the death of another infant who was given formula made by Abbott. The infant, who died in January, was found with Cronobacter bacteria. However, the FDA was notified about the mishap on June 10. Furthermore, four babies who were reported ill after receiving Abbott formula also had cronobacter infections. Turn of Events In February 2022, Abbott recalled formula, including Similac, after four babies became ill following the consumption of its products, of which two infants died.


Source:TipRanks
FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens
Jun 23, 2022 11:18am

Problems for Abbott Laboratories'' (NYSE: ABT ) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant''s death who was given formula made at Abbott''s Sturgis facility. According to a statement , the infant died in January, and the FDA was notified on June 10. "The investigation of this most recent consumer complaint is in its preliminary stages, and the agency will provide … Full story available on Benzinga.com


Source:Benzinga
Abbott Fund grants $750k to education, health equity program
Jun 23, 2022 00:00am

Easterseals announced that it received a $750,000 grant from the Abbott fund to pilot the Project on Education and Community Health Equity. The grant will fund the project from now through 2025, with the three-year initiative aimed at addressing systemic barriers to high-quality education and healthcare experienced by children and families in underserved communities. According […]


Source:WTWH
Baby formula warning after FDA investigates TENTH infant death linked to Abbott Laboratories
Jun 22, 2022 20:45pm

THE FDA has announced that it was notified of another baby formula-related infant death, new documents show. This comes after as many as nine children have died since early 2021 due to the formula possibly being contaminated at a Michigan factory. Abbott began a recall of its formula product in February and closed the Michigan […]


Source:The Sun
Abbott pares gains as FDA reports another death linked to baby formula (NYSE:ABT)
Jun 22, 2022 19:42pm

Abbott Laboratories (ABT) shed early gains on Wednesday after the FDA said that the agency was notified of an additional infant death linked to a company’s baby formula product on…


Source:Seeking Alpha
TI offering wireless microcontrollers that enable high-quality Bluetooth LE
Jun 22, 2022 00:00am

Texas Instruments (TI) has expanded its connectivity portfolio with a new family of wireless microcontrollers (MCU) that enable high-quality Bluetooth Low Energy (LE) at half the price of competing devices. Featuring best-in-class standby current and radio-frequency (RF) performance, the SimpleLink Bluetooth LE CC2340 family is built on the foundation of TI’s decades of wireless connectivity expertise.…


Source:WTWH
Illumina, Merck launch test for cancer development, progression insights
Jun 22, 2022 00:00am

Illumina (Nasdaq:ILMN) announced today that it launched a new research test, co-developed with Merck (NYSE:MRK). The jointly developed test adds the assessment of a new genomic signature to the already distributed TruSight Oncology 500 assay, enabling researchers to unlock deeper insights about the tumor genome by identifying genetic mutations used in the evaluation of homologous […]


Source:WTWH
Abbott to open new offices in downtown Chicago
Jun 22, 2022 00:00am

Abbott (NYSE: ABT) will open offices in the iconic Willis Tower in downtown Chicago, a company spokesperson confirmed to MassDevice. The company’s headquarters will stay in the northern suburbs, in Lake County, but the new downtown space will help accommodate flexible working arrangements for up to 450 Abbott employees, according to company spokesperson Scott Stoffel. […]


Source:WTWH
Illumina, Merck launch test for cancer development, progression insights
Jun 22, 2022 00:00am

Illumina (Nasdaq:ILMN) announced today that it launched a new research test, co-developed with Merck (NYSE:MRK). The jointly developed test adds the assessment of a new genomic signature to the already distributed TruSight Oncology 500 assay, enabling researchers to unlock deeper insights about the tumor genome by identifying genetic mutations used in the evaluation of homologous […]


Source:WTWH
Fluid power powerhouse Tom Wanke passes away
Jun 22, 2022 00:00am

Milwaukee School of Engineering is saddened to share the news that Tom Wanke, CFPE, director of the Fluid Power Industrial Consortium and Industry Relations, passed away June 21, 2022. Wanke began his nearly 50-year career at MSOE in 1974 as a technician in the university’s Fluid Power Institute (FPI) while he was pursuing an education…


Source:WTWH
Real Tested CBD and KCA Labs Partner to Provide Transparent Testing
Jun 21, 2022 00:00am

Real Tested CBD partnered with KCA Labs to work together in the mission to provide transparency in testing directly to CBD consumers. Because inaccurate test results can lead to serious consequences, Real Tested CBD is dedicated to bringing transparency to consumers through reliable, unbiased and accurate testing. “Our team at KCA was delighted to be chosen…


Source:WTWH
Finally, a Reasonable Price For This Healthcare Blue Chip
Jun 20, 2022 11:15am

Abbott Laboratories is a blue chip worth scooping up when it goes on sale.


Source:The Motley Fool
DTM Imola: Rookie Feller snares maiden pole in Abt Audi
Jun 19, 2022 09:05am


Source:Kwhen Finance